Biotricity, Inc. announced that it has entered into a securities purchase agreement to issue 55 shares of Series B Preferred Stock at a price of $9,090.91 per share for the gross proceeds of $500,000.05 on June 21, 2024. The shares will have a coupon rate of 8% and will be convertible at a conversion price of $3.50. The transaction included participation from returning investor, Ionic Ventures, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8997 USD | -2.94% | -5.29% | -21.77% |
06-27 | Transcript : Biotricity, Inc., Q4 2024 Earnings Call, Jun 27, 2024 | |
06-27 | Biotricity, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-21.77% | 19.47M | |
+0.56% | 3.35B | |
-9.32% | 165M | |
-16.67% | 80.81M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. announced that it has received $0.5 million in funding from Ionic Ventures, LLC